Proto Labs (PRLB) Expected to Release Quarterly Earnings on Friday

Proto Labs (NYSE:PRLB) will likely be issuing its Q2 2026 results before the market opens on Friday, July 31st. Analysts expect Proto Labs to post earnings of $0.54 per share and revenue of $144.5330 million for the quarter. Proto Labs has set its Q2 2026 guidance at 0.500-0.580 EPS. Parties are encouraged to explore the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Friday, July 31, 2026 at 8:30 AM ET.

Proto Labs (NYSE:PRLB) last released its earnings results on Friday, May 1st. The industrial products company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Proto Labs had a net margin of 4.71% and a return on equity of 4.15%. The firm had revenue of $139.34 million during the quarter, compared to the consensus estimate of $135.31 million. During the same period in the prior year, the firm earned $0.33 EPS. The company’s revenue was up 10.4% compared to the same quarter last year. On average, analysts expect Proto Labs to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Proto Labs Stock Down 1.5%

Shares of PRLB stock opened at $78.53 on Friday. The firm has a market cap of $1.87 billion, a P/E ratio of 74.08 and a beta of 1.38. The company has a 50 day moving average of $76.48 and a 200-day moving average of $65.88. Proto Labs has a 12-month low of $38.48 and a 12-month high of $83.15.

Insider Buying and Selling

In related news, insider Michael R. Kenison sold 16,030 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $69.49, for a total value of $1,113,924.70. Following the completion of the transaction, the insider directly owned 18,683 shares of the company’s stock, valued at approximately $1,298,281.67. This trade represents a 46.18% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Sven Wehrwein sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $77.28, for a total transaction of $154,560.00. Following the completion of the transaction, the director directly owned 32,505 shares of the company’s stock, valued at approximately $2,511,986.40. This trade represents a 5.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 25,663 shares of company stock worth $1,804,727 over the last 90 days. 1.30% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Proto Labs

A number of large investors have recently made changes to their positions in PRLB. Disciplined Growth Investors Inc. MN grew its position in shares of Proto Labs by 1.9% in the second quarter. Disciplined Growth Investors Inc. MN now owns 2,722,011 shares of the industrial products company’s stock valued at $108,989,000 after purchasing an additional 51,293 shares in the last quarter. Rubric Capital Management LP lifted its holdings in Proto Labs by 8.6% during the 3rd quarter. Rubric Capital Management LP now owns 1,123,338 shares of the industrial products company’s stock worth $56,201,000 after purchasing an additional 89,167 shares in the last quarter. American Capital Management Inc. boosted its stake in Proto Labs by 126.0% in the 4th quarter. American Capital Management Inc. now owns 631,311 shares of the industrial products company’s stock worth $31,938,000 after purchasing an additional 352,015 shares during the period. Arrowstreet Capital Limited Partnership boosted its stake in Proto Labs by 3.0% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 460,618 shares of the industrial products company’s stock worth $23,045,000 after purchasing an additional 13,488 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its holdings in Proto Labs by 9.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 363,013 shares of the industrial products company’s stock valued at $18,365,000 after buying an additional 31,585 shares in the last quarter. 84.54% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

PRLB has been the subject of a number of recent research reports. Benchmark raised their target price on Proto Labs from $70.00 to $91.00 and gave the stock a “buy” rating in a research report on Thursday, July 2nd. Wall Street Zen cut Proto Labs from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 18th. Zacks Research cut Proto Labs from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 3rd. Finally, Weiss Ratings upgraded Proto Labs from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, July 17th. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $65.33.

About Proto Labs

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.